Harmony Biosciences Holdings, Inc.

NASDAQ:HRMY

33.84 (USD) • At close November 13, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Omzet 186.038172.814154.615168.412160.268134.216119.126128.308117.206107.02885.31391.21380.73273.82159.67456.28845.60938.00519.845.995000
Kosten van de omzet 42.77838.10533.44543.15232.29625.00820.7826.88522.95918.92114.71617.81714.60412.68710.4099.9187.896.4563.4741.577000
Brutowinst 143.26134.709121.17125.26127.972109.20898.346101.42394.24788.10770.59773.39666.12861.13449.26546.3737.71931.54916.3664.418000
Brutowinstmarge 0.770.780.7840.7440.7980.8140.8260.790.8040.8230.8280.8050.8190.8280.8260.8240.8270.830.8250.737000
Onderzoek- en ontwikkelingskosten 25.38763.58322.18930.30617.49914.96913.28910.09240.54812.6687.5787.45111.7396.4984.6797.6184.234.1693.4317.2764.3364.99352.99
Algemene en administratieve kosten 28.58727.22425.67627.87222.54622.80922.06222.64321.33122.16317.8818.20516.85614.30214.54713.46610.5087.6289.2913.99412.565.8923.962
Verkoop- en marketingkosten 27.57628.50727.23326.88623.41824.52822.57221.07520.46720.1617.58319.10916.4817.02215.50617.52612.60112.44313.25416.84112.9088.3786.191
Verkoop-, algemene en administratieve kosten 56.16349.7746.94854.75845.96447.33744.63443.71841.79842.32335.46337.31433.33631.32430.05330.99223.10920.07122.54430.83525.46814.2710.153
Overige kosten 00.037-0.1410.193-0.005-0.0310.0020.0730.0560.042-0.0020.03100.004-0.020-1.525-0.400000
Bedrijfskosten 81.55113.35369.13785.06463.46362.30657.92353.8182.34654.99143.04144.76545.07537.82234.73238.6127.33924.2425.97538.11129.80419.26363.143
Bedrijfsresultaat 61.7121.35652.03340.19664.50946.90240.42347.61311.90133.11627.55628.63121.05323.31214.5337.7610.387.309-9.609-33.693-29.804-19.263-63.143
Bedrijfsresultaat ratio 0.3320.1240.3370.2390.4030.3490.3390.3710.1020.3090.3230.3140.2610.3160.2440.1380.2280.192-0.484-5.62000
Totaal overige inkomsten en kosten netto 0.460.338-0.248-0.507-12.677-2.807-2.643-3.51-3.934-3.885-4.171-4.156-31.575-7.223-7.147-7.966-8.471-7.336-29.011-2.747-2.095-1.3530.122
Inkomen voor belasting 62.1721.69451.78539.68951.83244.09537.7844.1037.96729.23123.38524.475-10.52216.0897.386-0.2061.909-0.027-38.62-36.44-31.899-20.616-63.021
Inkomen voor belasting ratio 0.3340.1260.3350.2360.3230.3290.3170.3440.0680.2730.2740.268-0.130.2180.124-0.0040.042-0.001-1.947-6.078000
Belastingkosten 16.07710.10313.45113.08213.3719.7958.295-4.406-79.9765.71.91.761-0.9021.9727.127-4.3835.4216.93629.0110000
Nettowinst 46.09311.59138.33426.60738.46134.329.48548.50987.94323.53121.48522.714-9.6214.1177.386-0.2061.909-0.027-38.62-36.44-31.899-20.616-63.021
Nettowinstmarge 0.2480.0670.2480.1580.240.2560.2480.3780.750.220.2520.249-0.1190.1910.124-0.0040.042-0.001-1.947-6.078000
WPA (Winst Per Aandeel) 0.810.20.680.460.640.570.490.821.480.40.360.39-0.170.250.13-0.004-0.14-0-0.7-0.66-0.58-0.37-1.14
Verwaterde WPA 0.790.20.670.450.630.560.480.791.440.390.350.38-0.170.240.13-0.004-0.14-0-0.7-0.66-0.58-0.37-1.14
EBITDA 72.48627.40858.15746.32170.61552.96646.48753.68117.96439.17132.75533.391-0.36128.04119.21212.14110.8229.313-7.726-31.748-28.751-19.14-63.054
EBITDA ratio 0.390.1590.3760.3640.4410.3490.390.3720.1540.3660.3840.3140.6430.380.3220.1380.2370.2450.752-5.296000